Loading...
The DREAM complex in anti-tumor activity of imatinib mesylate in gastrointestinal stromal tumors (GISTs)
PURPOSE OF REVIEW: Although most gastrointestinal stromal tumors (GISTs) respond well to treatment with the small molecule kinase inhibitor imatinib mesylate (Gleevec), the majority of patients achieve disease stabilization and complete remissions are rare. Furthermore, discontinuation of treatment...
Saved in:
| Published in: | Curr Opin Oncol |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
2014
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4236229/ https://ncbi.nlm.nih.gov/pubmed/24840522 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CCO.0000000000000090 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|